Market Tracker

03/23 5:16pm ET

Inspyr Therapeutics Inc (OTCQB:NSPX)

0.4475
Delayed Data
As of 3:17pm ET
 -0.0225 / -4.79%
Today’s Change
0.30
Today|||52-Week Range
5.01
-18.64%
Year-to-Date
No recent news for Inspyr Therapeutics Inc.

Today’s Trading

Previous close0.47
Today’s open0.45
Day’s range0.44 - 0.45
Volume7,688
Average volume (3 months)6,275
Market cap$657.1K
Dividend yield--
Data as of 3:17pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)+26.09%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$5.10
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Christopher P. Lowe
Chief Medical Officer &
Senior Vice President
Ronald L. Shazer
Corporate headquarters
San Antonio, Texas

Forecasts